Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs
Farmeconomia. Health economics and therapeutic pathways · 2009
DOI: 10.7175/fe.v10i3.173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Farmeconomia. Health economics and therapeutic pathways, 2009. Verfasst von Stefania Lopatriello und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The clinical pattern of Metastatic ColoRectal Cancer patients, receiving first-line infusional 5-FU or oral capecitabine (CAP) chemotherapies, was valorized in the perspective of the Italian NHS. A cost-minimization analysis was implemented on the basis of retrospective data from 5 centers. 202 subjects: 126 receiving 5-FU-association, 10 5-FU-monotherapy; 31 CAP-association, 35 CAP-monotherapy. Therapeutic patterns differed as to chemotherapy administration resources consumption: 5-FU was administered in Day Hospital and CAP in the outpatient setting. Mean total cost/patient was in the range of € 6,841 (monotherapy-5-FU)- € 12,620 (association-5-FU) and € 2,056 (monotherapy-CAP)-€ 9,745 (association-CAP). The infusional administration route of 5-FU was the driver of costs.
Zitieren
APA
Lopatriello, S., Negrini, C., Amoroso, D., & Donati, S. (2009). Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs. Farmeconomia. Health economics and therapeutic pathways. https://doi.org/10.7175/fe.v10i3.173
Vancouver
Lopatriello S, Negrini C, Amoroso D, Donati S. Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs. Farmeconomia. Health economics and therapeutic pathways. 2009. doi:10.7175/fe.v10i3.173
BibTeX
@article{Lopatriello2009,
author = {Lopatriello, Stefania and Negrini, Cristina and Amoroso, Domenico and Donati, Sara},
title = {Management of patients with metastatic colorectal cancer: economic consequences of different treatment programs},
journal = {Farmeconomia. Health economics and therapeutic pathways},
year = {2009},
doi = {10.7175/fe.v10i3.173}
}
EUVIMED